Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G van de Winkel

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Current Opinion in Infectious Diseases|October 13, 2006
Fc receptor and complement receptor-mediated phagocytosis in host defenceG Vidarsson, J G van de Winkel
International Reviews of Immunology|January 1, 1997
Human IgG Fc receptorsI A Heijnen, J G van de Winkel
Research in Immunology|January 1, 1990
Biological functioning of human IgG Fc receptorsJ G van de Winkel, C L Anderson
Journal of Leukocyte Biology|May 1, 1991
Biology of human immunoglobulin G Fc receptorsJ G van de Winkel, C L Anderson
Journal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de Winkel
Immunology Today|May 1, 1993
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsJ G van de Winkel, P J Capel
Immunology Today|September 1, 1990
Human Fc gamma receptor II: a standby receptor activated by proteolysis?W J Tax, J G van de Winkel
Current Opinion in Chemical Biology|July 27, 2001
Human antibodies as next generation therapeuticsM A van Dijk, J G van de Winkel
Immunogenetics|July 31, 1998
IgG receptor polymorphisms: risk factors for diseaseW van der Pol, J G van de Winkel
Journal of Biological Regulators and Homeostatic Agents|August 15, 2001
CD89 (Fc alphaRI)A B Van Spriel, J G van de Winkel
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Current Opinion in Infectious Diseases|October 13, 2006
Fc receptor and complement receptor-mediated phagocytosis in host defenceG Vidarsson, J G van de Winkel
International Reviews of Immunology|January 1, 1997
Human IgG Fc receptorsI A Heijnen, J G van de Winkel
Research in Immunology|January 1, 1990
Biological functioning of human IgG Fc receptorsJ G van de Winkel, C L Anderson
Journal of Leukocyte Biology|May 1, 1991
Biology of human immunoglobulin G Fc receptorsJ G van de Winkel, C L Anderson
Journal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de Winkel
Immunology Today|May 1, 1993
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsJ G van de Winkel, P J Capel
Immunology Today|September 1, 1990
Human Fc gamma receptor II: a standby receptor activated by proteolysis?W J Tax, J G van de Winkel
Current Opinion in Chemical Biology|July 27, 2001
Human antibodies as next generation therapeuticsM A van Dijk, J G van de Winkel
Immunogenetics|July 31, 1998
IgG receptor polymorphisms: risk factors for diseaseW van der Pol, J G van de Winkel
Journal of Biological Regulators and Homeostatic Agents|August 15, 2001
CD89 (Fc alphaRI)A B Van Spriel, J G van de Winkel
Pageof 17